Case Study: Bristol-Myers V. Kappos

Law360, New York (March 16, 2012, 1:33 PM EDT) -- On Jan. 27, 2012, the U.S. District Court for the District of Columbia held that the 180-day deadline to file a civil action seeking review of a patent term adjustment (PTA) determination by the U.S. Patent and Trademark Office is tolled by a timely filed petition for reconsideration of PTA with the USPTO.

Prior to this opinion, many patentees filed civil actions at the 180-day deadline in order to preserve the right of appeal in the federal courts for challenges that were still under USPTO review. This decision is significant because, barring a successful appeal by the USPTO, patentees may no...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS